Document:

Exhibit 10.1

 

Execution Version

 

AMENDMENT NO. 5 TO LOAN AND SECURITY
AGREEMENT

AMENDMENT NO. 5
TO LOAN AND SECURITY AGREEMENT, dated as of October 23, 2020 (this “Amendment No. 5”), is by and among SECURUS
365, INC., a Delaware corporation, EVANCE, INC., a Delaware corporation, EVANCE CAPITAL, INC., a Delaware corporation, OMNISOFT,
INC., a Delaware corporation and CROWDPAY.US, INC., a New York corporation, as borrowers (each a “Borrower”
and collectively, “Borrowers”), THE OLB GROUP, INC., a Delaware corporation, as parent guarantor (“Parent
Guarantor”), the financial institutions or other entities from time to time party hereto, each as a Lender and GACP FINANCE
CO., LLC as agent for the Lenders (in such capacity, the “Agent”).

W I T N E S S E T H :

WHEREAS, Agent,
Lenders, Borrowers and others have entered into financing arrangements pursuant to which Lenders (or Agent on behalf of Lenders)
have made and may make loans and advances and provide other financial accommodations to Borrowers as set forth in the Loan and
Security Agreement, dated as of April 9, 2018 (as amended, restated, amended and restated, supplemented or otherwise modified from
time to time, the “Credit Agreement”) and the other Loan Documents;

WHEREAS, Section
10.5 of the Credit Agreement provides that, among other things, the Borrowers, the Agent and the Required Lenders may make certain
amendments to the Credit Agreement and the other Loan Documents for certain purposes;

WHEREAS, the Loan
Parties have requested that Agent and the Lenders make certain amendments to the Credit Agreement, including the deletion of a
financial covenant, and Agent and the Lenders are agreeable to such request only on the terms and conditions set forth herein;
and

WHEREAS, by this
Amendment No. 5, Agent, Lenders signatory hereto and Loan Parties signatory hereto intend to evidence such amendments;

NOW, THEREFORE,
in consideration of the foregoing and the mutual agreements and covenants contained herein, the parties hereto agree as follows:

1.               
Interpretation. For purposes of this Amendment No. 5, all terms used herein which are not otherwise defined herein,
including, but not limited to, those terms used in the recitals hereto, shall have the respective meanings assigned thereto in
the Credit Agreement as amended by this Amendment No. 5.

2.               
Amendments.

(a)             
Section 1.1(b) of the Credit Agreement is hereby amended and restated to read as follows: “(i) An amount equal to
$1,000,000 of the principal of the Term Loan shall be repaid on July 30, 2018 (subject to prepayment on an earlier date to the
extent and in such amounts as required pursuant to Section 1.8(e)) (the “First Repayment”), (ii) an amount
equal to $2,000,000 of the principal of the Term Loan shall be repaid on October 31, 2018 (subject to prepayment on an earlier
date to the extent and in such amounts as required pursuant to Section 1.8(e)) (the “Second Repayment”
and together with the First Repayment, collectively, the “Repayment”), (iii) an amount equal to $125,000
of the principal of the Term Loan shall be repaid on or prior to April 24, 2020, (iv) a scheduled monthly payment of the principal
of the Term Loan of $25,000 per month, commencing May 1, 2020 and on the first Business Day of each calendar month thereafter through
and including October 1, 2020 (for a total of $150,000), (v) an amount equal to $450,000 of the principal of the Term Loan shall
be repaid on or prior to the date of this Amendment No. 5 and (vi) the remainder of the principal of the Term Loan shall be repaid
on the Maturity Date. The outstanding unpaid principal balance and all accrued and unpaid interest on the Term Loan shall be due
and payable on the earlier of (x) the Maturity Date, and (y) the date of the acceleration of the Term Loan in accordance with the
terms hereof. The Term Loan Commitments of the Lenders shall terminate on the date of making of the Term Loan. Any principal amount
of the Term Loan that is repaid or prepaid may not be reborrowed. All principal of, interest on, and other amounts payable in respect
of the Term Loan shall constitute Obligations hereunder. The Term Loan shall be made in and repayable in Dollars.”

    

     

    

(b)            
Section 5.18 of the Credit Agreement is hereby amended and restated to read as follows: “Until the later of the Maturity
Date and payment in full in cash of all of the Obligations the Borrowers shall maintain, at all times, in the Designated Deposit
Account a cash balance in an aggregate amount of not less than $1,000,000. The Designated Deposit Account (and cash in such Designated
Deposit Account, which for the avoidance of doubt shall at all times be not less than $1,000,000) shall be subject to the Designated
Deposit Account Control Agreement (in form and substance satisfactory to the Agent in its sole discretion), which Designated Deposit
Account Control Agreement shall not permit the Borrowers or any other Person (other than the Agent) to withdraw (or set-off) any
monies therein or therefrom if, as a result, cash on deposit therein would be less than $1,000,000 at any time without the Agent’s
prior written consent. If at any time there shall be less than $1,000,000 on deposit in the Designated Deposit Account, Agent shall
have the right to immediately restrict the Borrowers access to such Designated Deposit Account”.

(c)             
Section 5.24(a) of the Credit Agreement is hereby amended and restated to read as follows: “[Reserved]”.

(d)            
Section 5.26 is hereby added to the Credit Agreement to read as follows: “To the extent that Agent does not have online
view access of the Designated Deposit Account, on a weekly basis, the Loan Parties shall provide a balance report with respect
to the Designated Deposit Account, which report shall be either an electronic record generated by Wells Fargo Bank or via the Wells
Fargo Bank website or a bank statement for the Designated Deposit Account to the Agent. Such report shall be delivered no later
than the last Business Day of each week on or prior to 6:00 pm New York time via electronic mail, facsimile or certified mail.
From time to time, the Borrower shall also comply with the Agent’s other reasonable information requests with respect to
the Designated Deposit Account (within two (2) Business Days of request).”

(e)             
Section 7.1(c)(1) of the Credit Agreement is hereby amended and restated to read as follows: “(1) if (x) any Loan
Party defaults in the due observance or performance of any covenant, condition or agreement contained in Section 4.1, 4.7, 5.2
(limited to the last sentence of Section 5.2), 5.3, 5.14, 5.17, 5.18 (including the failure, at any time, to maintain a minimum
cash balance of at least $1,000,000 in the Designated Deposit Account), 5.23, 5.24 or 5.26, (ii) any “Event of Default”
(as defined in the Limited Recourse Guarantee and Pledge Agreement) has occurred or is continuing under the Limited Recourse Guarantee
and Pledge Agreement and/or (iii) any of the Borrowers default in the due observance or performance under Section 5 of the Amendment
No. 5; ”

(f)             
Schedule B is to the Credit Agreement is hereby amended by:

(i)    
 adding the following defined terms in alphabetical order:

(A)           
“Amendment No. 5” means the Amendment No. 5 to this Agreement dated as of October 23, 2020.

(B)           
“Designated Deposit Account” shall mean the “deposit account” of eVance, Inc. account number
4124924275 at Wells Fargo Bank, which “deposit account” is and shall at all times be subject to the Designated Deposit
Account Control Agreement and neither any Borrower nor any other Person (other than the Agent) shall withdraw (or set-off) any
monies therein or therefrom if, as a result, cash on deposit therein would be less than $1,000,000 at any time without the Agent’s
prior written consent.

    2

     

    

 

(C)           
“Designated Deposit Account Control Agreement” shall mean the Control Agreement (in form and substance
satisfactory to the Agent in its sole discretion) among the Borrowers, the Administrative Agent and Wells Fargo Bank as the bank
thereunder with respect to the Designated Deposit Account, which Control Agreement shall not permit the Borrowers or any other
Person (other than the Agent) to withdraw (or set-off) any monies from the Designated Deposit Account if, as a result, cash on
deposit in the Designated Deposit Account would be less than $1,000,000 at any time without the Agent’s prior written consent.

(ii)  
Amending an restating the defined term Loan Documents to read as follows: “Loan Documents” means,
collectively, this Agreement, all notes, guaranties, security agreements (including without limitation intellectual property security
agreements), mortgages, a perfection certificate in form and substance satisfactory to the Agent, certificates, landlord’s
agreements, Control Agreements (including the Designated Deposit Account Control Agreement), the Fee Letter, the Pledge Agreement,
the Limited Recourse Guarantee and Pledge Agreement, the Disclosure Schedule and all other agreements, documents and instruments
now or hereafter executed or delivered by any Loan Party in connection with, or to evidence the transactions contemplated by, this
Agreement.

3.               
Representations and Warranties. Each Loan Party, jointly and severally, hereby:

(a)             
reaffirms all representations and warranties made to Agent and Lenders under the Credit Agreement and all of the other Loan
Documents and confirms that each of the representations and warranties made by Loan Parties in or pursuant to the Credit Agreement,
the other Loan Documents and any related agreements to which it is a party, and each of the representations and warranties contained
in any certificate, document or financial or other statement furnished at any time under or in connection with this Agreement,
the other Loan Documents or any related agreement shall be true and correct in all material respects on and as of such date as
if made on and as of such date (or to the extent any representations or warranties are expressly made solely as of an earlier date,
such representations and warranties shall be true and correct in all material respects as of such earlier date); provided
that any representation and warranty that is qualified as to “materiality”, “Material Adverse Effect” or
similar language shall be true and correct (after giving effect to any qualification therein) in all respects on and as of such
date;

(b)            
reaffirms all of the covenants contained in the Credit Agreement and the other Loan Documents;

(c)             
represents and warrants that, other than the Existing Defaults, no Default and/or Event of Default has occurred and is continuing;

(d)            
represents and warrants that the execution, delivery and performance by each Loan Party of this Amendment No. 5 and the
other documents, agreements and instruments executed by any Loan Party in connection herewith (collectively, together with this
Amendment No. 5, the “Amendment Documents”) and the consummation of the transactions contemplated hereby or
thereby, are within such Loan Party’s powers, have been duly authorized by all necessary organizational action, and do not
contravene (i) the charter or by-laws or other organizational or governing documents of such Loan Party or (ii) any law
or any contractual restriction binding on or affecting any Loan Party, except, for purposes of this clause (ii), to the extent
such contravention would not reasonably be expected to have a Material Adverse Effect;

    3

     

    

 

(e)             
represents and warrants that no authorization or approval or other action by, and no notice to or filing with, any Governmental
Authority or any other third party is required for the due execution, delivery and performance by any Loan Party of any Amendment
Document to which it is a party that has not already been obtained if the failure to obtain such authorization, approval or other
action could reasonably be expected to result in a Material Adverse Effect; and

(f)             
represents and warrants that each Amendment Document has been duly executed and delivered by each Loan Party thereto. This
Amendment No. 5 constitutes, and each other Amendment Document will constitute upon execution, the legal, valid and binding obligation
of each Loan Party thereto enforceable against such Loan Party in accordance with its respective terms subject to the effect of
any applicable bankruptcy, insolvency, reorganization or moratorium or similar laws affecting the rights of creditors generally
and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity).

4.               
Conditions Precedent. This Amendment No. 5 shall be effective on the date of the satisfaction of each of the following
conditions precedent:

(a)             
Agent shall have received counterparts of this Amendment No. 5, duly authorized, executed and delivered by Borrowers, Parent
Guarantor, Agent and the Lenders;

(b)            
Agent shall have received for the benefit of the Lender a payment of $450,000 for repayment of principal on the Term Loan
required by Section 1.1(b)(v) of the Credit Agreement as amended by this Amendment No. 5;

(c)             
Borrowers shall have established the Designated Deposit Account and deposited not less than $1,000,000 into it (along with
providing documentary evidence thereof to the Agent);

(d)            
Borrower shall have paid all expenses of Agent and Lenders (including legal fees and costs of Kramer Levin Naftalis &
Frankel LLP);

(e)             
No Default and/or Event of Default shall have occurred and be continuing; and

(f)             
The representations and warranties contained in Section 4 and in the Credit Agreement shall be true and correct in all material
respects on and as of such date as if made on and as of such date (except to the extent expressly relating to an earlier date,
in which case such representation and warranty shall be true and correct as of such earlier date).

5.     
Conditions Subsequent. On or prior to December 31, 2020 (or such later date as the Agent may agree in its sole discretion),
either (a) Agent shall have received duly executed “springing” Control Agreements with respect to each Deposit Account
(other than Restricted Accounts) (including without limitation account number 4527440994 at Wells Fargo Bank and account number
457441000 at Wells Fargo Bank) of each Loan Party for which Agent has not previously received a Control Agreement or (b) each such
Deposit Account (other than Restricted Accounts) of each Loan Party for which Agent has not previously received a Control Agreement
shall be closed; provided that until Agent’s receipt of a “springing” Control Agreements to the extent
any such Deposit Account remains open, the aggregate balance in all such Deposit Accounts shall not at any time exceed $150,000.
Failure to deliver the Control Agreements (or close the applicable Deposit Accounts) in accordance with the foregoing sentence
shall be an immediate Event of Default under Section 7.1 of the Credit Agreement as if set forth therein.

    4

     

    

 

6.               
General.

(a)             
Effect of this Amendment No. 5. Except as expressly provided herein, no other consents, waivers, changes or modifications
to the Loan Documents are intended or implied, and in all other respects the Loan Documents are hereby specifically ratified, restated
and confirmed by all parties hereto as of the date hereof.

(b)            
Fees. Borrower agrees to pay on demand all expenses of Agent and Lenders in connection with the preparation, negotiation,
execution, delivery and administration of this Amendment No. 5.

(c)             
Governing Law. This Amendment No. 5 shall be governed by, and construed in accordance with, the laws of the State
of New York, without regard to conflicts of laws principles thereof.

(d)            
Waiver of Jury Trial. SECTION 10.16 OF THE CREDIT AGREEMENT IS HEREBY INCORPORATED BY REFERENCE INTO THIS AMENDMENT
NO. 5 MUTATIS MUTANDIS AND SHALL APPLY HERETO AS IF ORIGINALLY MADE A PART HEREOF.

(e)             
Binding Effect. This Amendment No. 5 shall bind and inure to the benefit of the respective successors and permitted
assigns of each of the parties hereto.

(f)             
Counterparts, etc. This Amendment No. 5 may be executed in any number of counterparts and by different parties hereto
in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall
constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Amendment No. 5 by telecopier
or by electronic transmission of a pdf formatted counterpart shall be effective as delivery of a manually executed counterpart
of this Amendment No. 5.

(g)            
Loan Document. Each of this Amendment No. 5 and the Designated Deposit Account Control Agreement constitute a Loan
Document.

(h)            
Reaffirmation. Each of the undersigned Loan Parties acknowledges (i) all of its Obligations under the Credit Agreement
and each other Loan Document to which it is a party are reaffirmed and remain in full force and effect on a continuous basis, (ii)
its grant of security interests pursuant to the Loan Documents are reaffirmed and remain in full force and effect after giving
effect to this Amendment No. 5, (iii) the Obligations include, among other things and without limitation, the due and punctual
payment of the principal of, interest on, and premium (if any) on the Loans and (iv) except as expressly provided herein, the execution
of this Amendment No. 5 shall not operate as a waiver of any right, power or remedy of Agent or any Lender, constitute a waiver
of any provision of any of the Loan Documents or serve to effect a novation of the Obligations.

(i)              
Release. In consideration of the agreements of Agent and Lenders contained herein and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, each Loan Party signatory hereto, on behalf of itself
and its respective successors, assigns, and other legal representatives, hereby absolutely, unconditionally and irrevocably releases,
remises and forever discharges Agent and Lenders, and their successors and assigns, and their present and former shareholders,
affiliates, subsidiaries, divisions, predecessors, directors, officers, attorneys, employees, agents and other representatives
(Agent, each Lender and all such other Persons being hereinafter referred to collectively as the “Releasees”
and individually as a “Releasee”), of and from all demands, actions, causes of action, suits, covenants, contracts,
controversies, agreements, promises, sums of money, accounts, bills, reckonings, damages and any and all other claims, counterclaims,
defenses, rights of set off, demands and liabilities whatsoever (individually, a “Claim” and collectively, “Claims”)
of every name and nature, known as of the date of this Amendment No. 5, both at law and in equity, which each Loan Party signatory
hereto, or any of its respective successors, assigns, or other legal representatives may now or hereafter own, hold, have or claim
to have against the Releasees or any of them for, upon, or by reason of any circumstance, action, cause or thing whatsoever which
arises at any time on or prior to the day and date of this Amendment No. 5, in each case for or on account of, or in relation to,
or in any way in connection with any of the Credit Agreement, or any of the other Loan Documents or transactions thereunder or
related thereto.

[Remainder of Page
Intentionally Left Blank]

 

 

    5

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Amendment No. 5 to be duly executed and delivered by their authorized officers as of the day
and year first above written.

	 	THE OLB GROUP, INC.,	 
	 	as Parent Guarantor	 
	 	 	 
	 	By: 	 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	SECURUS365, INC.,	 
	 	as a Borrower	 
	 	 	 
	 	By: 	 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	EVANCE, INC.,	 
	 	as a Borrower	 
	 	 	 
	 	By: 	 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	EVANCE CAPITAL, INC.,	 
	 	as a Borrower	 
	 	 	 
	 	By: 	 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	OMNISOFT, INC.,	 
	 	as a Borrower	 
	 	 	 	 
	 	By:	 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	CROWDPAY.US, INC.,	 
	 	as a Borrower	 
	 	 	 
	 	By: 	 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	By:	 	 
	 	 	Name:	 
	 	 	Title:	 

 

Amendment No. 5 to Credit Agreement

    

     

    

 

	AGENT:	GACP FINANCE CO., LLC, as Agent	 
	 	 	 	 
	 	By:	 	 
	 	 	 	 
	 	 	 	 
	LENDERS: 	GACP I, L.P., as Lender	 
	 	 	 	 
	 	By:	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 

 

 

Amendment No. 5 to Credit AgreementExhibit 4.1

 

THIS WARRANT AND THE SECURITIES ISSUABLE
UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES
LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A REGISTRATION
STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER SUCH ACT AND QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS, OR
AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION AND QUALIFICATION IS NOT REQUIRED.

 

BIOHITECH GLOBAL, INC.

 

COMMON STOCK PURCHASE WARRANT

 

	Warrant Shares: ____	Issue Date:  October  __, 2020

 

 

THIS COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, __________, a New York limited liability
company or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise
and the conditions hereinafter set forth, to purchase from the Company at any time after the Issue Date until 5:00 p.m., E.S.T
on the fifth (5th) anniversary of the Issue Date (the “Termination Date”) but not thereafter,
to subscribe for and purchase from BioHiTech Global, Inc., a Delaware corporation (the “Company”), up
to Fifty Thousand (50,000) shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common
Stock, par value $0.0001 per share (the “Common Stock”). The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as set forth below.

 

The following
is a statement of the rights of the Holder of this Warrant and the conditions to which this Warrant is subject, to which the Holder,
by the acceptance of this Warrant, agrees:

 

1.         Certain
Definitions.

 

1.1         “Exercise
Price” means a price per share equal to the price per share, as measured by the average of the high and low prices
as published on the Nasdaq Capital Market on the issue date set forth above.

 

1.2         “Expiration
Date” means the date that is five (5) years after the issue date set forth above.

 

1.3         “Shares”
or “Warrant Shares” means the shares of Common Stock issuable under this Warrant, as set forth above.

 

2.         Number
of Shares and Exercise.

 

     

     

    

 

2.1         This
Warrant shall be exercisable for such number of Warrant Shares as set forth above, at the Exercise Price.

 

2.2         This
Warrant may be exercised in whole or in part at any time beginning on the date on which the Initial Exercise Date and continuing
thereafter and from time to time on or prior to the Expiration Date.

 

3.          Exercise
of Warrant

 

3.1         The
purchase rights represented by this Warrant are exercisable by the Holder, in whole or in part, by the surrender of this Warrant
and the Notice of Exercise annexed hereto duly executed at the Company’s principal executive office (or such other office
or agent of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books
of the Company), and upon payment of the aggregate Exercise Price of the Shares thereby purchased (by check or bank draft payable
to the order of the Company); whereupon the Holder shall be entitled to receive the number of Shares so purchased. The Company
agrees that if at the time of the surrender of this Warrant and purchase of the Shares, the Holder shall be entitled to exercise
this Warrant, the Shares so purchased shall be issued to the Holder as the record owner of such Shares as of the close of business
on the date on which this Warrant shall have been exercised as aforesaid or on such later date requested by the Holder or on such
earlier date agreed to by the Holder and the Company.

 

3.2       Delivery
of Common Stock Certificates and New Warrant. As soon as reasonably practicable after each exercise of this Warrant, in
whole or in part, and in any event within five (5) business days thereafter (the “Warrant Share Delivery Date”),
the Company, at its expense (including the payment by it of any applicable issue taxes), will cause the name of the Holder (or
as Holder may direct) to be entered in the register of holders in respect of the Warrant Shares and further cause to be issued
in the name of and delivered to the Holder hereof or as the Holder (upon payment by the Holder of any applicable transfer taxes)
may direct:

 

(a)         the
number of duly authorized, validly issued, fully paid and nonassessable Warrant Shares to which the Holder shall be entitled upon
exercise, in certificated form with appropriate restrictive legends, if applicable; and

 

(b)         in
case exercise is in part only, a new Warrant document of like tenor, dated the date hereof, for the remaining number of Warrant
Shares issuable upon exercise of this Warrant after giving effect to the partial exercise of this Warrant (including the delivery
of any Warrant Shares as payment of the Exercise Price for such partial exercise of this Warrant).

 

4.          Nonassessable.
The Company covenants that all Shares which may be issued upon the exercise of this Warrant will be validly issued, fully paid
and nonassessable and free from all taxes, liens and charges in respect of the issue thereof.

 

5.          Fractional
Shares. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.
With respect to any fraction of a share called for upon the exercise of this Warrant, the number of shares delivered shall be rounded
up to the nearest whole share.

 

     

     

    

 

6.          Charges,
Taxes and Expenses. Issuance of Shares upon the exercise of this Warrant, in certificated form or otherwise, shall be made
without charge to the Holder hereof for any issue or transfer tax or other incidental expense in respect of the issuance, including
relating to any certificate, all of which taxes and expenses shall be paid by the Company, and such Shares shall be issued in the
name of the Holder.

 

7.         No
Rights as Shareholders. This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder
of the Company prior to the exercise hereof.

 

8.           Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall be a Saturday, a Sunday or a legal holiday, then such action may be taken or such right may be exercised
on the next succeeding day that is not a Saturday, Sunday or legal holiday.

 

9.           Adjustments.
The Exercise Price and the number of Shares purchasable hereunder are subject to adjustment from time to time as set forth in this
Section 9.

 

9.1       Reclassification,
etc. If the Company, at any time while this Warrant, or any portion thereof, remains outstanding and unexpired, by reclassification
of securities or otherwise, shall change the class of the securities as to which purchase rights under this Warrant exist into
the same or a different number of securities or any other class or classes of securities, this Warrant shall thereafter represent
the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to
the securities that were subject to the purchase rights under this Warrant immediately prior to such reclassification or other
change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section
9.

 

9.2       Subdivision
or Combination of Shares. In the event the Company shall at any time subdivide the outstanding securities as to which
purchase rights under this Warrant exist, or shall issue a stock dividend on the securities as to which purchase rights under this
Warrant exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such subdivision
or to the issuance of such stock dividend shall be proportionately increased, and the Exercise Price shall be proportionately decreased,
and in the event that the Company shall at any time combine the outstanding securities as to which purchase rights under this Warrant
exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such combination shall
be proportionately decreased, and the Exercise Price shall be proportionately increased, effective at the close of business on
the date of such subdivision, stock dividend or combination, as the case may be.

 

9.3       Cash
Distributions. No adjustment on account of cash dividends or interest on the securities as to which purchase rights under
this Warrant exist will be made to the Exercise Price under this Warrant.

 

10.         Miscellaneous.

 

10.1      Loss,
Theft, Destruction or Mutilation of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, delivery of an indemnity agreement
reasonably satisfactory in form and substance to the Company or, in the case of mutilation, on surrender and cancellation of this
Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new Warrant executed in the same manner as this Warrant
and of like tenor and amount.

 

     

     

    

 

10.2      Waivers
and Amendments. This Warrant and the obligations of the Company and the rights of the Holder under this Warrant may be
amended, waived, discharged or terminated (either generally or in a particular instance, either retroactively or prospectively
and either for a specified period of time or indefinitely) with the written consent of the Company (which shall not be required
in connection with a waiver of rights in favor of the Company); provided, however, that no such amendment
or waiver shall reduce the number of Shares represented by this Warrant without the consent of the Holder hereof; and provided
further, however, that nothing shall prevent the Holder from individually agreeing to waive the observation of any term of
this Warrant. Any amendment, waiver, discharge or termination effected in accordance with this Section 10.2 shall be binding upon
the Company, the Holder, and except pursuant to a waiver by an individual holder of another Warrant pursuant to the final proviso
in the immediately preceding sentence, each other holder of Warrants.

 

10.3      Notices. Any
notice, request or other communication required or permitted hereunder shall be given in writing and given by registered or certified
mail, return receipt requested, or by Federal Express or other recognized overnight courier requiring a receipt upon delivery,
addressed to the registered address of the party or to such address as any party may designate in writing to all other parties
in accordance with this paragraph.

 

10.4      Severability. If
one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision(s) shall be excluded from
this Warrant and the balance of this Warrant shall be interpreted as if such provision(s) were so excluded and shall be enforceable
in accordance with its terms.

 

10.5      Successors
and Assigns. Neither this Warrant nor any rights hereunder are transferable without the prior written consent of
the Company. Notwithstanding the foregoing, the Holder shall be permitted to transfer this Warrant to any affiliate (as that term
is defined in the Securities Act of 1933, as amended) of the Holder. If a transfer is permitted pursuant to this Section, the transfer
shall be recorded on the books of the Company upon the surrender of this Warrant, properly endorsed, to the Company at its principal
offices, and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. In the event
of a partial transfer, the Company shall issue to the holders one or more appropriate new warrants. Subject to the foregoing, the
provisions of this Warrant shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators
of the Company and the Holder.

 

10.6      Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to the Holder, upon any breach or
default of the Company under this Warrant shall impair any such right, power, or remedy of the Holder nor shall it be construed
to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter
occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default therefore or
thereafter occurring. Any waiver, permit, consent, or approval of any kind or character on the part of the Holder of any breach
or default under this Warrant or any waiver on the part of the Holder of any provisions or conditions of this Warrant must be made
in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Warrant
or by law or otherwise afforded to the Holder, shall be cumulative and not alternative.

 

     

     

    

 

10.7      Titles
and Subtitles. The titles of the paragraphs and subparagraphs of this Warrant are for convenience of reference only and
are not to be considered in construing this Warrant.

 

10.8      Construction. The
language used in this Warrant will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.

 

10.9      Governing
Law. THIS WARRANT SHALL BE GOVERNED IN ALL RESPECTS BY THE LAWS OF THE STATE OF DELAWARE AS SUCH LAWS ARE APPLIED TO AGREEMENTS
BETWEEN DELAWARE RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN DELAWARE.

 

[Remainder of page intentionally
left blank]

 

     

     

    

 

 

IN WITNESS WHEREOF,
BioHiTech Global, Inc. has caused this Warrant to be executed by its officer thereunto duly authorized.

  

  

	BIOHITECH GLOBAL, INC. 	 
	 	 
	 	 	 
	By: 	 	 
	 	Name:	 
	 	Title:	 

 

 

 

 

 

     

     

    

 

 

THIS WARRANT AND THE SECURITIES ISSUABLE
UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES
LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A REGISTRATION
STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER SUCH ACT AND QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS, OR
AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION AND QUALIFICATION IS NOT REQUIRED.

 

BIOHITECH GLOBAL, INC.

 

COMMON STOCK PURCHASE WARRANT

 

	Warrant Shares: 50,000	Issue Date:  October 19, 2020

 

 

THIS COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, LEK HOLDINGS, LLC, a New York limited liability
company or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise
and the conditions hereinafter set forth, to purchase from the Company at any time after the Issue Date until 5:00 p.m., E.S.T
on the fifth (5th) anniversary of the Issue Date (the “Termination Date”) but not thereafter,
to subscribe for and purchase from BioHiTech Global, Inc., a Delaware corporation (the “Company”), up
to Fifty Thousand (50,000) shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common
Stock, par value $0.0001 per share (the “Common Stock”). The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as set forth below.

 

The following
is a statement of the rights of the Holder of this Warrant and the conditions to which this Warrant is subject, to which the Holder,
by the acceptance of this Warrant, agrees:

 

1.         Certain
Definitions.

 

1.1         “Exercise
Price” means a price per share equal to the price per share, as measured by the average of the high and low prices
as published on the Nasdaq Capital Market on the issue date set forth above.

 

1.2         “Expiration
Date” means the date that is five (5) years after the issue date set forth above.

 

1.3         “Shares”
or “Warrant Shares” means the shares of Common Stock issuable under this Warrant, as set forth above.

 

2.         Number
of Shares and Exercise.

 

     

     

    

 

2.1         This
Warrant shall be exercisable for such number of Warrant Shares as set forth above, at the Exercise Price.

 

2.2         This
Warrant may be exercised in whole or in part at any time beginning on the date on which the Initial Exercise Date and continuing
thereafter and from time to time on or prior to the Expiration Date.

 

3.          Exercise
of Warrant

 

3.1         The
purchase rights represented by this Warrant are exercisable by the Holder, in whole or in part, by the surrender of this Warrant
and the Notice of Exercise annexed hereto duly executed at the Company’s principal executive office (or such other office
or agent of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books
of the Company), and upon payment of the aggregate Exercise Price of the Shares thereby purchased (by check or bank draft payable
to the order of the Company); whereupon the Holder shall be entitled to receive the number of Shares so purchased. The Company
agrees that if at the time of the surrender of this Warrant and purchase of the Shares, the Holder shall be entitled to exercise
this Warrant, the Shares so purchased shall be issued to the Holder as the record owner of such Shares as of the close of business
on the date on which this Warrant shall have been exercised as aforesaid or on such later date requested by the Holder or on such
earlier date agreed to by the Holder and the Company.

 

3.2       Delivery
of Common Stock Certificates and New Warrant. As soon as reasonably practicable after each exercise of this Warrant, in
whole or in part, and in any event within five (5) business days thereafter (the “Warrant Share Delivery Date”),
the Company, at its expense (including the payment by it of any applicable issue taxes), will cause the name of the Holder (or
as Holder may direct) to be entered in the register of holders in respect of the Warrant Shares and further cause to be issued
in the name of and delivered to the Holder hereof or as the Holder (upon payment by the Holder of any applicable transfer taxes)
may direct:

 

(a)         the
number of duly authorized, validly issued, fully paid and nonassessable Warrant Shares to which the Holder shall be entitled upon
exercise, in certificated form with appropriate restrictive legends, if applicable; and

 

(b)         in
case exercise is in part only, a new Warrant document of like tenor, dated the date hereof, for the remaining number of Warrant
Shares issuable upon exercise of this Warrant after giving effect to the partial exercise of this Warrant (including the delivery
of any Warrant Shares as payment of the Exercise Price for such partial exercise of this Warrant).

 

4.          Nonassessable.
The Company covenants that all Shares which may be issued upon the exercise of this Warrant will be validly issued, fully paid
and nonassessable and free from all taxes, liens and charges in respect of the issue thereof.

 

5.          Fractional
Shares. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.
With respect to any fraction of a share called for upon the exercise of this Warrant, the number of shares delivered shall be rounded
up to the nearest whole share.

 

     

     

    

 

6.          Charges,
Taxes and Expenses. Issuance of Shares upon the exercise of this Warrant, in certificated form or otherwise, shall be made
without charge to the Holder hereof for any issue or transfer tax or other incidental expense in respect of the issuance, including
relating to any certificate, all of which taxes and expenses shall be paid by the Company, and such Shares shall be issued in the
name of the Holder.

 

7.         No
Rights as Shareholders. This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder
of the Company prior to the exercise hereof.

 

8.           Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall be a Saturday, a Sunday or a legal holiday, then such action may be taken or such right may be exercised
on the next succeeding day that is not a Saturday, Sunday or legal holiday.

 

9.           Adjustments.
The Exercise Price and the number of Shares purchasable hereunder are subject to adjustment from time to time as set forth in this
Section 9.

 

9.1       Reclassification,
etc. If the Company, at any time while this Warrant, or any portion thereof, remains outstanding and unexpired, by reclassification
of securities or otherwise, shall change the class of the securities as to which purchase rights under this Warrant exist into
the same or a different number of securities or any other class or classes of securities, this Warrant shall thereafter represent
the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to
the securities that were subject to the purchase rights under this Warrant immediately prior to such reclassification or other
change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section
9.

 

9.2       Subdivision
or Combination of Shares. In the event the Company shall at any time subdivide the outstanding securities as to which
purchase rights under this Warrant exist, or shall issue a stock dividend on the securities as to which purchase rights under this
Warrant exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such subdivision
or to the issuance of such stock dividend shall be proportionately increased, and the Exercise Price shall be proportionately decreased,
and in the event that the Company shall at any time combine the outstanding securities as to which purchase rights under this Warrant
exist, the number of securities as to which purchase rights under this Warrant exist immediately prior to such combination shall
be proportionately decreased, and the Exercise Price shall be proportionately increased, effective at the close of business on
the date of such subdivision, stock dividend or combination, as the case may be.

 

9.3       Cash
Distributions. No adjustment on account of cash dividends or interest on the securities as to which purchase rights under
this Warrant exist will be made to the Exercise Price under this Warrant.

 

10.         Miscellaneous.

 

10.1      Loss,
Theft, Destruction or Mutilation of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, delivery of an indemnity agreement
reasonably satisfactory in form and substance to the Company or, in the case of mutilation, on surrender and cancellation of this
Warrant, the Company shall execute and deliver, in lieu of this Warrant, a new Warrant executed in the same manner as this Warrant
and of like tenor and amount.

 

     

     

    

 

10.2      Waivers
and Amendments. This Warrant and the obligations of the Company and the rights of the Holder under this Warrant may be
amended, waived, discharged or terminated (either generally or in a particular instance, either retroactively or prospectively
and either for a specified period of time or indefinitely) with the written consent of the Company (which shall not be required
in connection with a waiver of rights in favor of the Company); provided, however, that no such amendment
or waiver shall reduce the number of Shares represented by this Warrant without the consent of the Holder hereof; and provided
further, however, that nothing shall prevent the Holder from individually agreeing to waive the observation of any term of
this Warrant. Any amendment, waiver, discharge or termination effected in accordance with this Section 10.2 shall be binding upon
the Company, the Holder, and except pursuant to a waiver by an individual holder of another Warrant pursuant to the final proviso
in the immediately preceding sentence, each other holder of Warrants.

 

10.3      Notices. Any
notice, request or other communication required or permitted hereunder shall be given in writing and given by registered or certified
mail, return receipt requested, or by Federal Express or other recognized overnight courier requiring a receipt upon delivery,
addressed to the registered address of the party or to such address as any party may designate in writing to all other parties
in accordance with this paragraph.

 

10.4      Severability. If
one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision(s) shall be excluded from
this Warrant and the balance of this Warrant shall be interpreted as if such provision(s) were so excluded and shall be enforceable
in accordance with its terms.

 

10.5      Successors
and Assigns. Neither this Warrant nor any rights hereunder are transferable without the prior written consent of
the Company. Notwithstanding the foregoing, the Holder shall be permitted to transfer this Warrant to any affiliate (as that term
is defined in the Securities Act of 1933, as amended) of the Holder. If a transfer is permitted pursuant to this Section, the transfer
shall be recorded on the books of the Company upon the surrender of this Warrant, properly endorsed, to the Company at its principal
offices, and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. In the event
of a partial transfer, the Company shall issue to the holders one or more appropriate new warrants. Subject to the foregoing, the
provisions of this Warrant shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators
of the Company and the Holder.

 

10.6      Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to the Holder, upon any breach or
default of the Company under this Warrant shall impair any such right, power, or remedy of the Holder nor shall it be construed
to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter
occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default therefore or
thereafter occurring. Any waiver, permit, consent, or approval of any kind or character on the part of the Holder of any breach
or default under this Warrant or any waiver on the part of the Holder of any provisions or conditions of this Warrant must be made
in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Warrant
or by law or otherwise afforded to the Holder, shall be cumulative and not alternative.

 

     

     

    

 

10.7      Titles
and Subtitles. The titles of the paragraphs and subparagraphs of this Warrant are for convenience of reference only and
are not to be considered in construing this Warrant.

 

10.8      Construction. The
language used in this Warrant will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.

 

10.9      Governing
Law. THIS WARRANT SHALL BE GOVERNED IN ALL RESPECTS BY THE LAWS OF THE STATE OF DELAWARE AS SUCH LAWS ARE APPLIED TO AGREEMENTS
BETWEEN DELAWARE RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN DELAWARE.

 

[Remainder of page intentionally
left blank]

 

     

     

    

 

 

IN WITNESS WHEREOF,
BioHiTech Global, Inc. has caused this Warrant to be executed by its officer thereunto duly authorized.

 

 

	BIOHITECH GLOBAL, INC. 	 
	 	 
	 	 	 
	By: 	 	 
	 	Name:	 
	 	Title:	 

  

     

     

    

 

NOTICE OF EXERCISE

 

	 	TO:	BioHiTech Global, Inc.
	 	 	80 Red Schoolhouse Road, Suite 101
	 	 	Chestnut Ridge, NY 10977
	 	 	Attn: Secretary

 

 

The undersigned hereby elects to purchase _______ shares (the
“Shares”) of the Common Stock of BioHiTech Global, Inc. pursuant to the terms of the attached Warrant
and tenders herewith payment of the purchase price in full.

 

Please issue the Shares, including in certificated form with
appropriate restrictive legends, if applicable, in the name of the undersigned or in such other name as is specified below:

 

	 
	(Print Name)

 

 

	Address:	 	 
	 	 
	 	 

 

The undersigned confirms that the undersigned
is an “accredited investor” within the meaning of Rule 501 of Regulation D under the Securities Act of 1933, as amended,
and that the Shares are being acquired for the account of the undersigned for investment only and not with a view to, or for resale
in connection with, the distribution thereof, and that the undersigned has no present intention of distributing or selling the
Shares.

 

	 	 	 
	(Date)	 	(Signature)
	 	 	 
	 	 	 
	(Print Name)	 	 

 

 

 

     

     

    

 

 

Exhibit C – Amended and Restated
Operating Agreement

 

See Attached

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]